Clinical Trial Update: Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism [Phase 2]

View source ↗

Summary

Phase 2 trial in children with autism evaluated pharmacokinetics, safety, efficacy, and tolerability of memantine. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Forest Laboratories | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2014-01-14